RZLT CIK: 1509261

Rezolute, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−39.6
FY23:
−44.5
FY24:
−57.4
FY25:
−69.1
FY26:
−64.6
Change from FY23 to FY26
millions USD
FY22:
–
FY23:
−101
FY24:
48.7
FY25:
−14.5
FY26:
−21.1
Change from FY22 to FY26
millions USD
FY22:
149
FY23:
11.6
FY24:
63.0
FY25:
107
FY26:
2.24
millions USD
FY22:
109
FY23:
−134
FY24:
54.4
FY25:
23.7
FY26:
−83.5
(positive)
millions USD
FY22:
–
FY23:
−44.6
FY24:
–
FY25:
–
FY26:
–

All amounts in millions USD Data source:SEC EDGAR